These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9043851)

  • 1. Growth hormone and heart performance. A novel mechanism of cardiac wall stress regulation in humans.
    Fazio S; Cittadini A; Sabatini D; Merola B; Colao A; Biondi B; Longobardi S; Lombardi G; Saccà L
    Eur Heart J; 1997 Feb; 18(2):340-7. PubMed ID: 9043851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy.
    Fazio S; Sabatini D; Capaldo B; Vigorito C; Giordano A; Guida R; Pardo F; Biondi B; Saccà L
    N Engl J Med; 1996 Mar; 334(13):809-14. PubMed ID: 8596546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study.
    Fazio S; Cittadini A; Sabatini D; Merola B; Colao AM; Biondi B; Lombardi G; Saccá L
    Eur Heart J; 1993 Jan; 14(1):26-33. PubMed ID: 8432287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular consequences of early-onset growth hormone excess.
    Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac size and function in acromegaly.
    Martins JB; Kerber RE; Sherman BM; Marcus ML; Ehrhardt JC
    Circulation; 1977 Nov; 56(5):863-9. PubMed ID: 144034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acromegalic cardiopathy: a morphofunctional study with color-Doppler echocardiography].
    Cavalli G; De Gregorio C; Nicosia S; Cannavò S; Aragona A; Trimarchi F; Arrigo F; De Gregorio G
    Ann Ital Med Int; 1992; 7(3):141-7. PubMed ID: 1457253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systolic and diastolic cardiac function in acromegaly. An echocardiographic study.
    Galanti G; Cappelli B; Diricatti G; Mininni S; Vono MC; Gensini GF
    Ann Ital Med Int; 1996; 11(1):27-32. PubMed ID: 8645527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Growth hormone and the heart].
    Fazio S; Sabatini D; Cittadini A; Biondi B; Merola B; Colao A; Longobardi S; Lombardi G; Saccà L
    Cardiologia; 1993 Aug; 38(8):513-8. PubMed ID: 8313406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly.
    Fazio S; Cittadini A; Cuocolo A; Merola B; Sabatini D; Colao A; Biondi B; Lombardi G; Saccà L
    J Clin Endocrinol Metab; 1994 Aug; 79(2):441-6. PubMed ID: 8045960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac effect of thyrotoxicosis in acromegaly.
    Marzullo P; Cuocolo A; Ferone D; Pivonello R; Salvatore M; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of hypertension and hypertension-related left ventricle hypertrophy on right ventricle function.
    Tumuklu MM; Erkorkmaz U; Ocal A
    Echocardiography; 2007 Apr; 24(4):374-84. PubMed ID: 17381646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
    Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired cardiac performance in elderly patients with growth hormone deficiency.
    Colao A; Cuocolo A; Di Somma C; Cerbone G; Della Morte AM; Nicolai E; Lucci R; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3950-5. PubMed ID: 10566633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone therapy and the heart.
    Climent VE; Picó A; Sogorb F; Aznar S; Lip GY; Marín F
    Am J Cardiol; 2006 Apr; 97(7):1097-102. PubMed ID: 16563925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
    Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wall stress determines systolic and diastolic function--Characteristics of heart failure.
    Alter P; Koczulla AR; Nell C; Figiel JH; Vogelmeier CF; Rominger MB
    Int J Cardiol; 2016 Jan; 202():685-93. PubMed ID: 26454537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac performance in Turner's syndrome patients on growth hormone therapy.
    Radetti G; Crepaz R; Milanesi O; Paganini C; Cesaro A; Rigon F; Pitscheider W
    Horm Res; 2001; 55(5):240-4. PubMed ID: 11740146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise-Induced Left Ventricular Remodeling Among Competitive Athletes: A Phasic Phenomenon.
    Weiner RB; DeLuca JR; Wang F; Lin J; Wasfy MM; Berkstresser B; Stöhr E; Shave R; Lewis GD; Hutter AM; Picard MH; Baggish AL
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26666381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.